Dissolution enhancement of albendazole through nanocrystal formulation.

D Krishna Koradia, H Rajesh Parikh
Author Information
  1. D Krishna Koradia: Department of Pharmaceutics and Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Anand, Gujarat, India.

Abstract

Albendazole, a BCS class II drug, has poor dissolution characteristic. In order to enhance dissolution nanocrystals were prepared by antisolvent precipitation process using PVP K-30(0.05%,0.1%,0.2%,0.4%) as stabilizer. The process was optimized in terms of concentration of stabilizer(PVP K 30) in order to enhance dissolution and obtain stable particles with a small mean particle size. Nanocrystals were characterized with respect to particle size, in vitro dissolution and X-ray diffraction pattern. Decrease in particle size of nanocrystals was observed with increase in concentration of stabilizer. Dissolution of nanocrystals also improved with increase in concentration of PVP K-30. Crystalline state evaluation before and following particle size reduction was conducted through XRD to denote any possible transformation to an amorphous state during process.

Keywords

References

  1. Arch Med Res. 1999 Sep-Oct;30(5):368-74 [PMID: 10596455]

Word Cloud

Created with Highcharts 10.0.0dissolutionnanocrystals0particlesizeprocessPVPstabilizerconcentrationAlbendazoleorderenhanceK-30increaseDissolutionstateenhancementBCSclassIIdrugpoorcharacteristicpreparedantisolventprecipitationusing05%1%2%4%optimizedtermsK30obtainstableparticlessmallmeanNanocrystalscharacterizedrespectvitroX-raydiffractionpatternDecreaseobservedalsoimprovedCrystallineevaluationfollowingreductionconductedXRDdenotepossibletransformationamorphousalbendazolenanocrystalformulation

Similar Articles

Cited By